Back to Resource Center

Multipurpose Prevention Technologies: Strategy recommendations to guide the most promising products from the lab to hands of women

Multipurpose Prevention Technologies: Strategy recommendations to guide the most promising products from the lab to hands of women

Recent results from long-acting HIV prevention trials in parallel with the MPTs in the pipeline herald an exciting time for the MPT field. However, given finite resources and technical challenges to advance products from preclinical through clinical evaluation, objective benchmark criteria would be useful to identify and guide the most promising pre-clinical MPT candidates through the pipeline. This presentation at the HIVR4P 2021 Conference describes MPTs in development and a strategy for bridging funding and development gaps.

Download Poster
View Conference Abstract

January 2021

Click for full info +

Multipurpose Prevention Technologies: Strategy recommendations to guide the most promising products from the lab to hands of women

January, 2021

Recent results from long-acting HIV prevention trials in parallel with the MPTs in the pipeline herald an exciting time for the MPT field. However, given finite resources and technical challenges to advance products from preclinical through clinical evaluation, objective benchmark criteria would be useful to identify and guide the most promising pre-clinical MPT candidates through the pipeline. This presentation at the HIVR4P 2021 Conference describes MPTs in development and a strategy for bridging funding and development gaps.

In this Presentation:

Full Info:


Resource Type:

Presentation Convenings

Authors: Bethany Young Holt, Susanna Moore, Anke Hemmerling, Kavita Nanda, Greg Kopf, Thesla Palanee-Phillips, Sharon L. Achilles

Health Risks(s):

  • HIV
  • STI / STD
  • Unintended Pregnancy

Product type(s):

  • MPTs

Topic(s):

  • MPTs
  • Development

Region(s)

  • Global

Back to Resource Center